Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Coulter announces positive investigational phase III results from Bexxar in NHL

Oct. 22, 1998

No Comments

Endorex adds second site to phase II ImmTher trial

Oct. 16, 1998

No Comments

Rituximab now available in Germany

Oct. 14, 1998

No Comments

Antibody-based cancer product from AltaRex heading for phase I testing

Oct. 14, 1998

No Comments

Coulter initiates expanded access program for Bexxar

Oct. 8, 1998

No Comments

Patent issued for Neoprobe's RIGS/ACT anticancer technology

Oct. 7, 1998

No Comments

Genentech's Herceptin given FDA approval

Sep. 28, 1998

No Comments

Enzon's PEG-Intron A advances to phase III trials for malignant melanoma

Sep. 24, 1998

No Comments

Procyon receives Japanese patent for prostate cancer treatment

Sep. 24, 1998

No Comments

Theratope cancer vaccine study fulfills enrollment

Sep. 23, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immuno-oncology
RSS

Coulter announces positive investigational phase III results from Bexxar in NHL

Endorex adds second site to phase II ImmTher trial

Rituximab now available in Germany

Antibody-based cancer product from AltaRex heading for phase I testing

Coulter initiates expanded access program for Bexxar

Patent issued for Neoprobe's RIGS/ACT anticancer technology

Genentech's Herceptin given FDA approval

Enzon's PEG-Intron A advances to phase III trials for malignant melanoma

Procyon receives Japanese patent for prostate cancer treatment

Theratope cancer vaccine study fulfills enrollment

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Immuno-oncology RSS

Immuno-oncology
RSS